Literature DB >> 28434526

AJKD Atlas of Renal Pathology: Calcineurin Inhibitor Nephrotoxicity.

Mark A Lusco1, Agnes B Fogo2, Behzad Najafian3, Charles E Alpers3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28434526     DOI： 10.1053/j.ajkd.2017.02.003

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  4 in total

1.  Steroid Sensitive Nephrotic Syndrome: Revised Guidelines.

Authors:  Aditi Sinha; Arvind Bagga; Sushmita Banerjee; Kirtisudha Mishra; Amarjeet Mehta; Indira Agarwal; Susan Uthup; Abhijeet Saha; Om Prakash Mishra
Journal:  Indian Pediatr       Date:  2021-03-20       Impact factor: 1.411

2.  Osmotic Tubulopathy and Acute Thrombotic Microangiopathy in a Kidney Transplant Recipient With a Breakthrough SARS-CoV-2 Infection.

Authors:  Peter Fahim; Anthony Nicolaysen; Julie M Yabu; Jonathan E Zuckerman
Journal:  Kidney Med       Date:  2022-05-26

Review 3.  Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis.

Authors:  Tianyi Xia; Sang Zhu; Yan Wen; Shouhong Gao; Mingming Li; Xia Tao; Feng Zhang; Wansheng Chen
Journal:  Drug Des Devel Ther       Date:  2018-02-28       Impact factor: 4.162

4.  Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design.

Authors:  Liron Walsh; John F Reilly; Caitlin Cornwall; Gregory A Gaich; Debbie S Gipson; Hiddo J L Heerspink; Leslie Johnson; Howard Trachtman; Katherine R Tuttle; Youssef M K Farag; Krishna Padmanabhan; Xin-Ru Pan-Zhou; James R Woodworth; Frank S Czerwiec
Journal:  Kidney Int Rep       Date:  2021-07-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.